SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Glenmark Life Scienc - Quaterly Results

24 Oct 2024 Evaluate
A decrease in the sales to Rs. 5068.79 millions was observed for the quarter ended September 2024. The sales stood at Rs. 5953.63 millions during the similar quarter previous year.The Net proft of the company remain more or less same to Rs. 953.16  millions from Rs. 1187.37 millions ,decline by -19.73%.A decline of 1428.92 millions was observed in the OP in the quarter ended September 2024 from 1724.53 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 5068.79 5953.63 -14.86 10954.95 11738.13 -6.67 22832.14 21612.20 5.64
Other Income 85.33 53.69 58.93 140.26 72.20 94.27 120.42 289.57 -58.41
PBIDT 1428.92 1724.53 -17.14 3078.70 3674.65 -16.22 6862.88 6712.50 2.24
Interest 3.43 3.99 -14.04 6.96 7.95 -12.45 15.46 5.47 182.63
PBDT 1425.49 1720.54 -17.15 3071.74 3666.70 -16.23 6847.42 6707.03 2.09
Depreciation 150.93 131.29 14.96 294.80 257.41 14.53 534.52 420.94 26.98
PBT 1274.56 1589.25 -19.80 2776.94 3409.29 -18.55 6312.90 6286.09 0.43
TAX 321.40 401.88 -20.03 708.95 867.42 -18.27 1604.02 1616.48 -0.77
Deferred Tax 19.00 14.88 27.69 31.38 44.43 -29.37 81.88 110.37 -25.81
PAT 953.16 1187.37 -19.73 2067.99 2541.87 -18.64 4708.88 4669.61 0.84
Equity 245.06 245.05 0.00 245.06 245.05 0.00 245.05 245.05 0.00
PBIDTM(%) 28.19 28.97 -2.68 28.10 31.31 -10.23 30.06 31.06 -3.22

Alivus Life Sciences Share Price

1066.65 -6.50 (-0.61%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×